Liquor Control Board Recommendations for Medical Marijuana - NBC Right Now/KNDO/KNDU Tri-Cities, Yakima, WA |

Liquor Control Board Recommendations for Medical Marijuana Regulation

Posted: Updated:

OLYMPIA, WA - The Washington State Liquor Control Board is giving a clearer picture of how it thinks the Legislature should regulate medical marijuana. 

On Wednesday, the board issued recommendations on Monday, a proviso of the state operating budget directed the Liquor Control Board to work with the departments of Revenue and Health to develop recommendations regarding the interaction of medical marijuana regulations and the emerging recreational marijuana system. 

Staff from the three agencies prepared draft recommendations for the Board in eight categories that included possession amounts, medical marijuana authorizing requirements, taxation and other topics.

The Board reviewed written public input and had a public meeting back in November before drafting the recommendations.

The Board accepted many of the staff recommendations with one major exception regarding the recommended prohibition on home growing of medical marijuana. Board members are recommending allowing authorized medical marijuana patients up to six plants for personal use. 

Below, you'll find a complete list of the Washington State Liquor Control Board's recommendations for medical marijuana regulation.

1. Age limits 

• Adults 18 to 20 years old should be allowed access to medical marijuana with proper  authorization from a health care professional. 

• Children 17 years old or younger should be allowed access to medical marijuana with parent or  guardian consent to the authorization. The parent or guardian should participate in the child's treatment.  

• Re-examinations occur at least once every year or more frequently as medically indicated.

• The child's parent or guardian should be required to act as the child's designated provider and be  entered in the registry as such.  

• The parent or guardian should have sole control over the child's medical marijuana. The child  should be allowed to possess no more medical marijuana than necessary for his or her next dose.  

• Medical marijuana consumed in a school setting should be held and administered by school  personnel in the same manner as any other medication. Consistent with current law, schools should not be compelled to accommodate on-site use of medical marijuana on school grounds or school buses. 

• Medical marijuana products should be prohibited from being labeled in a manner that mimics  candy, soda or other treats attractive to children.    

Under I-502: A person must be 21 years old to legally possess marijuana, to hold a marijuana license or enter a licensed marijuana premise.  

2. Authorizing requirements for medical marijuana 

• A mandatory patient and designated provider registry should be established and maintained by  the Department of Health.  

• The registry should be mandatory for all patients as a condition of receiving an authorization.

• The registry should be used to determine eligibility for exemption from state and local retail sales  and use taxes on marijuana purchases by qualified patients. 

• Designated providers should be required to participate in the registry in conjunction with the  patient. 

• Patient and designated provider information should be entered into the registry by the authorizing  health care professional. The information must contain sufficient unique identifiers (Washington driver's license or identification card number) to ensure accurate identification of the patient or designated provider.  

• Registration should expire annually and the patient or designated provider may be re-entered in  the registry only after a new or follow-up examination. 

• Cards should be issued from the registry to identify patients and designated providers.  

• The registry should be available to law enforcement and to the Department of Revenue as  necessary to verify tax-exempt purchases under Title 82 RCW. 

• Disciplining authorities for the health care professions allowed to authorize medical marijuana  should have access to the registry to monitor compliance by their licensees. 

• Consistent and reliable funding must be provided to establish and maintain the registry.  

• The registry should contain sufficient security features to protect patient privacy. Information in  the registry that could identify patients should be excluded from public disclosure. 

• All existing authorizations should expire on a date certain to coincide with full implementation of  the registry and retail market. All patients with existing authorizations would need to be re-evaluated by a health care professional pursuant to the revised standards and placed in the registry within a designated timeframe. 

• Authorization system should not place an undue burden on healthcare providers.   

Under I-502:  N/A  

3. Regulations regarding health care professionals 

• Require the Department of Health, in consultation with medical professional stakeholders, to  define "debilitating" and "intractable pain" to clearly indicate the condition must be severe enough to significantly interfere with the patient's activities of daily living and ability to function, and can be objectively assessed and evaluated. 

• Enact comprehensive requirements defining the standard of care for health care professionals  who authorize medical marijuana similar to those required by ESHB 2876 (2010) regarding the use of opioids to manage chronic pain. The requirements should address topics such as adequacy of examination, follow-up care and recording keeping.  

• Restrict a health care professional's practice to ensure it does not consist primarily of authorizing  medical marijuana. Any restrictions regarding what percentage of a health care provider's practice can or should be devoted to authorizing medical marijuana shall not be considered to set a statutory precedent for limitations on other services provided by a health care provider. The boards and commissions that license health care providers who may authorize medical marijuana shall develop guidelines and/or rules to monitor and regulate the scope of a provider practice to ensure it does not consist primarily of authorizing medical marijuana.   

• Require a permanent physical location for a health care professional's place of practice.

• Require in person examinations for authorizations.

• Require an expiration of authorizations to ensure a regular cycle of re-examination and follow-up  care. Re-examination should occur at least once a year or more frequently as medically indicated. 

• Continue to allow the provision for petitions to add qualifying conditions and amend the statute,  RCW 69.51A.070, to allow the Medical Quality Assurance Commission to make a preliminary finding of good cause prior to holding a hearing and expand the time frame for the hearing to be completed. 

Under I-502:  N/A  

4. Collective gardens Eliminate Collective Gardens.  

Under I-502:  N/A  

5. Possession amounts 

• Reduce the amount a qualified patient or designated provider can possess at any given time from  twenty-four ounces of useable marijuana to three ounces.  Allow additional limits for marijuana infused products in solid or liquid form. 

• Allow home grows and the ability for a qualified patient or designated provider to possess  marijuana plants. A qualified patient or designated provider may possess 6 plants, 3 flowering and 3 nonflowering. Define "plant" to avoid any misinterpretation of this provision. 

• Require labeling to include the levels of tetrahydrocannabinol (THC) and cannabinoids in medical  marijuana products. 

• Restrict labeling and marketing of medical marijuana products to ensure that they are not  intentionally attractive to minors or recreational users. 

• Continue to allow the provision in RCW 69.51A.045 that grants qualified patients or designated  providers an affirmative defense to criminal charges of possession above the legal amount if they can prove at trial the patient's necessary medical use exceeds the amount determined in law.   

Under I-502:  One ounce of useable marijuana; 16 ounces of marijuana infused product in solid form; and 72 ounces of marijuana infused product in liquid form.  

6. Location requirements

There would not be specific medical marijuana location requirements because only I-502 licensed retail stores may sell marijuana and accept medical marijuana authorization cards.  

Under I-502: Medical marijuana licensed business cannot be within one thousand feet of the perimeter of the grounds of any of the following entities: 

1. Elementary or secondary school; 

2. Playground; 

3. Recreational center or facility; 

4. Child care center; 

5. Public park; 

6. Public transit center; 

7. Library; 

8. Any game arcade where admission is not restricted to persons age twenty-one or older.   


7. Requirements for medical marijuana producing, processing and retail licensing

Integrate medical and recreational marijuana producers, processors and retailers into one licensing system. Only recreational marijuana retailers with an endorsement may accept medical marijuana authorization cards. Make the new regulatory system for medical marijuana effective no sooner than January 1, 2015.  

Under I-502:  

1. Three separate license tiers: producer, processor and retailer; 

2. A licensee may hold both a producer and processor license simultaneously, but not a retailer  license; 

3. Open registration for all license types for a 30-day window; 

4. Three month state residency requirement to qualify for a license; 

5. Personal criminal history, fingerprint and background checks of applicants; 

6. Point system for all arrests and/or convictions; 

7. License limits; 

8. Production limits; 

9. Maximum allowable amount of marijuana on licensed locations.  


8. Taxation of medical marijuana in relation to recreational marijuana

Utilize the same tax structure as recreational marijuana, but provide an exemption from state and local retail sales and use taxes on purchases by medical marijuana patients registered with the Department of Health.  

Under I-502:  

1. Producers  

   a. Pay 25% excise tax on wholesale sales* 

   b. Pay B&O tax as wholesaler  

2. Processors  

   a. Pay 25% excise tax on wholesale sales* 

   b. Pay B&O tax as manufacturer 

3. Retailers 

   a. Pay 25% excise tax on retail sales 

   b. Pay B&O tax as retailer 

   c. Collect state/local retail sales & use tax 

4. Retail Buyers 

   a. Pay state/local retail sales & use tax   


* This level of tax may not apply to certain producer/processor licensees. 


Click here for a PDF version of the above recommendations.